Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-12-05 4:00 pm Purchase | 2025-12-01 | 13G | PASITHEA THERAPEUTICS CORP COM KTTA | Vivo Opportunity Fund Holdings, L.P. | 17,560,467 9.990% | 17,560,467![]() (New Position) | Filing History |
| 2025-11-14 6:38 pm Purchase | 2025-09-30 | 13G | BRIGHT MINDS BIOSCIENCES INC C DRUG | Vivo Opportunity Fund Holdings, L.P. | 454,184 6.400% | 454,184![]() (New Position) | Filing History |
| 2025-11-14 6:37 pm Sale | 2025-09-30 | 13G | COMPASS PATHWAYS PLC SPONSORED CMPS | Vivo Opportunity Fund Holdings, L.P. | 3,174,494 3.200% | -3,174,494![]() (-50.00%) | Filing History |
| 2025-11-14 6:35 pm Purchase | 2025-09-30 | 13G | COMPASS THERAPEUTICS INC CMPX | Vivo Opportunity Fund Holdings, L.P. | 8,995,979 5.100% | 8,995,979![]() (New Position) | Filing History |
| 2025-11-14 6:35 pm Sale | 2025-09-30 | 13G | SOLENO THERAPEUTICS INC PA SLNO | Vivo Opportunity Fund Holdings, L.P. | 2,251,160 4.200% | -1,707,134![]() (-43.13%) | Filing History |
| 2025-11-14 6:34 pm Purchase | 2025-09-30 | 13G | UNICYCIVE THERAPEUTICS INC UNCY | Vivo Opportunity Fund Holdings, L.P. | 6,096,175 9.990% | 2![]() (+0.00%) | Filing History |
| 2025-10-03 4:30 pm Purchase | 2025-09-29 | 13G | SAB BIOTHERAPEUTICS INC NE SABS | Vivo Opportunity Fund Holdings, L.P. | 25,931,000 9.990% | 25,931,000![]() (New Position) | Filing History |
| 2025-09-17 6:31 pm Purchase | 2025-09-11 | 13G | CAMP4 THERAPEUTICS CORP COM CAMP | Vivo Opportunity Fund Holdings, L.P. | 3,561,793 7.600% | 3,561,793![]() (New Position) | Filing History |
| 2025-08-12 8:52 pm Sale | 2025-06-30 | 13G | SOLENO THERAPEUTICS INC PA SLNO | Vivo Opportunity Fund Holdings, L.P. | 3,958,294 7.400% | -500,000![]() (-11.22%) | Filing History |
| 2025-08-12 8:50 pm Purchase | 2025-06-30 | 13G | CIDARA THERAPEUTICS INC NE CDTX | Vivo Opportunity Fund Holdings, L.P. | 1,175,796 4.600% | 563,520![]() (+92.04%) | Filing History |
| 2025-05-15 08:35 am Sale | 2025-03-31 | 13G | REGULUS THERAPEUTICS INC P RGLS | Vivo Opportunity Fund Holdings, L.P. | 2,696,426 3.900% | -2,303,574![]() (-46.07%) | Filing History |
| 2025-05-15 08:33 am Sale | 2025-03-31 | 13G | DELCATH SYS INC DCTH | Vivo Opportunity Fund Holdings, L.P. | 750,195 2.200% | -958,384![]() (-56.09%) | Filing History |
| 2025-05-15 08:32 am Purchase | 2025-03-31 | 13G | COMPASS PATHWAYS PLC SPONSORED CMPS | Vivo Opportunity Fund Holdings, L.P. | 6,348,988 6.600% | 3,132,988![]() (+97.42%) | Filing History |
| 2025-05-15 08:31 am Purchase | 2025-03-31 | 13G | CIDARA THERAPEUTICS INC NE CDTX | Vivo Opportunity Fund Holdings, L.P. | 612,276 4.700% | 12,119![]() (+2.02%) | Filing History |
| 2025-05-15 08:30 am Unchanged | 2025-03-31 | 13G | UNICYCIVE THERAPEUTICS INC UNCY | Vivo Opportunity Fund Holdings, L.P. | 6,096,173 9.990% | 0 (Unchanged) | Filing History |
| 2025-04-08 6:15 pm Purchase | 2025-04-07 | 13G | DBV TECHNOLOGIES S.A. ADR DBVT | Vivo Opportunity Fund Holdings, L.P. | 20,358,470 9.990% | 20,358,470![]() (New Position) | Filing History |
| 2025-03-31 8:00 pm Sale | 2025-03-31 | 13G | SOLENO THERAPEUTICS INC PA SLNO | Vivo Opportunity Fund Holdings, L.P. | 4,458,294 9.700% | -1,833,557![]() (-29.14%) | Filing History |
| 2024-12-09 5:37 pm Purchase | 2024-11-26 | 13G | CIDARA THERAPEUTICS INC NE CDTX | Vivo Opportunity Fund Holdings, L.P. | 600,157 5.500% | 600,157![]() (New Position) | Filing History |
| 2024-11-21 4:51 pm Purchase | 2024-11-19 | 13G | ACLARIS THERAPEUTICS INC ACRS | Vivo Opportunity Fund Holdings, L.P. | 7,955,160 7.400% | 7,955,160![]() (New Position) | Filing History |
| 2024-11-14 7:02 pm Sale | 2024-09-30 | 13G | DELCATH SYS INC DCTH | Vivo Opportunity Fund Holdings, L.P. | 1,708,579 5.300% | -1,000,000![]() (-36.92%) | Filing History |

